Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells

American Journal of Otology

Volumn 18, Issue 5, 1997, Pages 559-571

  Kopke, Richard D ^a   Liu, Wei ^a   Gabaizadeh, Ramin ^a   Jacono, Andrew ^a   Feghali, Joseph ^a   Spray, David ^a   Garcia, Phil ^a   Steinman, Howard ^a   Malgrange, Bridgitte ^b   Ruben, Robert J ^a   Rybak, Leonard ^c   Van De Water, Thomas R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant molecules; Auditory hair cells; Cisplatin; Corti's organ; Organotypic cultures

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CISPLATIN; EBSELEN; GLUTATHIONE; GLUTATHIONE ETHYL ESTER; HYDROGEN PEROXIDE; METHIONINE; PHENYLISOPROPYLADENOSINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; COCHLEA; CONTROLLED STUDY; CORTI ORGAN; DOSE RESPONSE; EAR PROTECTION; HAIR CELL; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; FREE RADICALS; HAIR CELLS; ORGAN OF CORTI; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 12644293785     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Gandara DR, Perez EA, Phillips HJ, et al. Evaluation of cisplatin dose intensity: current status and future prospects. Anticancer Res 1989;9:1121-8.
2. Kopelman J, Budnick AS, Sessions RB, et al. Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 1988;98:858-64.
3. Harrison LB, Pfister DG, Fass DE, et al. Concomitant chemotherapy-radiation therapy followed by hyper fractionated radiation therapy for advanced unresectable head and neck cancer. Radiat Oncol Biol Phys 1991;21:703-8.
4. Berry MJ, Jacobs C, Sikic B, et al. Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 1990;8:1585-90.
5. McHaney VA, Thibadoux G, Hayes FA, et al. Hearing loss in children receiving cisplatin chemotherapy. J Pediatr 1983;102:314-7.
6. Schell MJ, McHaney VA, Green AA. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol 1989;7:754-60.
7. Weatherly RA, Owens JI, Catlin FI, et al. Cis-platinum ototoxicity in children. Laryngoscope 1991;101:917-24.
8. Estrem SA, Babin RW, Ryu JH, et al. Diamminedichloroplatinum (II) ototoxicity in the guinea pig. Otolaryngol Head Neck Surg 1981;89:638-745.
9. Tange RA, Conijn EA, van Zeijl LG. The Cortitoxic effects of cisplatinum in the guinea pig. Arch Otorhinolaryngol 1982;237: 17-26.
10. Anniko M, Sobin A. Cisplatin: evaluation of its ototoxic potential. Am J Otol 1986;7:276-93.
11. Laurell G, Bagger-Sjoback D. Degeneration of the organ of Corti following intravenous administration of cisplatin. Acta Otolaryngol (Stockh) 1991;111:891-8.
12. Schweitzer VG. Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents. Laryngoscope 1993;103:1-52.
13. Hinojosa R, Riggs LC, Strauss M, et al. Temporal bone histopathology of cisplatin ototoxicity. Am J Otol 1995;16:731-41.
14. Spiro DC, Rhys-Evans PH, Osborne MP, et al. Early morphological and chemical changes induced by cisplatin in the guinea pig organ of Corti. J Laryngol Otol 1986;100:1375-83.
15. Sugihara KS, Gemba M. Modification of cisplatin toxicity by antioxidants. Jpn J Pharmacol 1986;40:353-5.
16. Sugihara KS, Nakano M, Koda K, et al. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 1987;43:247-52.
17. Hannemann J, Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 1988;51:119-32.
18. Appenroth D, Winnefeld K, Schroter H, et al. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats. J Appl Toxicol 1993;13:189-92.
19. Appenroth D, Winnefeld K. Role of glutathione for cisplatin nephrotoxicity in young and adult rats. Renal Failure 1993;15:135-9.
20. Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol 1995;26:293-300.
21. Ravi, R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995;76:386-94.
22. Freeman BA, Capo JD. Biology of disease: free radicals and tissue injury. Lab Invest 1982;47:412-26.
23. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal: applications in research and therapy. Pharmacol Ther 1991;51:155-94.
24. Pierson MG, Gray BM. Superoxide dismutase activity in the cochlea. Hear Res 1982;6:141-51.
25. El Barbary A, Altschuler RA, Schacht J. Glutathione-s-transferases in the organ of Corti of the rat: enzymatic activity, subunit composition and immunohistochemical localization. Hear Res 1993; 71:80-90.
26. Jacono AA, Kopke RD, Vugmeyster L, et al. Changes in cochlear antioxidant enzyme levels after conditioning noise exposure in the chinchilla. Abstracts of the 19th ARO Midwinter Meeting, St. Petersburg, FL, 1996 (Absract 132).
27. Lefebvre PP, Malgrange B, Staecker H, et al. Retinoic acid stimulates regeneration of mammalian auditory hair cells. Science 1993; 260:692-5.
28. Levy A, Anderson ME, Meister A. Transport of glutathione diethyl ester into human cells. Proc Natl Acad Sci USA 1993;90:9171-5.
29. 2 in cultured endothelial cells. Arch Biochem Biophys 1993; 302:348-55.
30. Kane DJ, Sarafian TA, Rein A, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262:1274-7.
31. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121-6.
32. Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985;113:484-9.
33. Seelig G, Meister A. Glutathione biosynthesis: gamma-glutamyl cysteine synthetase from rat kidney. Methods Enzymol 1995;113: 379-90.
34. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step mercapturic acid formation. J Biol Chem 249:7130-9.
35. Naganuma A, Anderson ME, Meister A. Cellular glutathione as a determinant of sensitivity to mercuric chloride toxicity. Biochem Pharmacol 1990;40:693-7.
36. Jain A, Martenson J, Stole E, et al. Glutathione deficiency leads to mitochondrial damage in brain. Proc Natl Acad Sci U S A 1991; 88:1913-7.
37. Malaher K, Hurwitz S, Bump E, et al. Pharmacodynamics of prolonged treatment with L.S-buthionine sulfoximine. Int J Radiat Oncol Biol Phys 1994;29:407-12.
38. Cotgreave I, Moldeus P, Schuppe I. The metabolism of N-acetylcysteine by human endothelial cells. Biochem Pharmacol 1991; 42:13-4.
39. Peterson TC, Brown IR. Cysteamine in combination with N-acetylcysteine prevents acetaminophen-induced hepatotoxicity. Can J Physiol Pharmacol 1992;70:20-8.
40. Holdiness M. Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmcokinet 1991;20:123-34.
41. Maggirwar SB, Dhanraj DN, Somani SM, et al. Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 1994;201:508-15.
42. Ford MS, Maggirwar SB, Whitworth CP, et al. Purinoceptor agonist stimulates antioxidant enzymes in the cochlea of chinchilla. Soc Neurosci Abstr 1995;21:910.
43. Anderson ME, Naganuma A, Meister A. Protection against cisplatin toxicity by administration of glutathione ester. FASEB J 1990; 4:3251-5.
44. Sadzuka Y, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 1992;43:1872-5.
45. Richardson GP, Russell IJ. Cochlear cultures as a model system for studying aminoglycoside ototoxicity. Hear Res 1991;53:293-311.
46. Kotecha BI, Richardson GP. Ototoxicity in vitro: effects of neomycin, gentamicin. Hear Res 1994;73:173-84.
47. Anniko M, Takada A, Schacht J, et al. Comparative ototoxicities of gentamicin and netilmicin in three model systems. Am J Otolaryngol 1982;3:422-33.
48. Li L, Forge A. Cultured explants of the vestibular sensory epithelia from adult guinea pigs and effects of gentamicin. Auditory Neurosci 1995;1:111-25.
49. Carlier E, Pujol R. Supra-normal sensitivity to ototoxic antiobiotic of the developing rat cochlea. Arch Otorhinolaryngol 1980;226: 129-33.
50. Ratan RR, Murphy TH, Baraban JM. Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione. J Neurosci 1994;14:4385-92.
51. Aruoma OI, Halliwell B, Hoeg BM. The antioxidant action of N-acetyl-cysteine: its reaction with hydrogen peroxide, hydroxyl radical, a superoxide, and hypochlorous acid. Free Radic Biol Med 1989;6:593-7.
52. Sies H. Ebselen, a selenoorganic compound as a glutathione peroxidase mimic. Free Rad Biol Med 1993;14:313-23.
53. Noguchi N, Yoshida Y, Kaneda H, et al. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol 1992;44: 39-44
54. Boogaard PJ, Lempers ELM, Mulder GJ, et al. 4-methylthiobenzoic acid reduces cisplatin nephrotoxicity in rats without compromising anti-tumor activity. Biochem Pharmacol 1991;41: 1997-2003.
55. Baldew GS, McVie GJ, van der Valk MA, et al. Selective reduction of cis-diamminedichloroplatinum (II) nephrotoxicity by ebselen. Can Res 1990;50:7031-6.
56. Jones MM, Basinger MA. Thiol and thioether suppression of cisplatinum-induced nephrotoxicity in rats bearing the Walker 256 carcinosarcoma. Anticancer Res 1989;9:1937-42.
57. Basinger M, Jones ME, Holscher MA. L-methionine antagonism of cis-platinum nephrotoxicity. Toxicol Appl Pharmacol 1990;103: 1-15.
58. Lempers ELM, Reedijk J. Reversibility of cisplatin-methionine in proteins by diethyldithiocarbamate or thiourea: a study of model adducts. Inorganic Chem 1990;29:217-22.
59. Campbell KC, Rybak LP, Meech RP et al. D-methionine provides complete protection from cisplatin olotoxicity in the rat. Hear Res 1996;102:90-8.
60. Rybak L, Whitworth C, Morris C. Effect of ebselen on cisplatin ototoxicity. 19th ARO Midwinter Meeting. St. Petersburg, FL, 1996 (Absract 122).
61. Morris C, Husain K, Whitworth I, et al. 4-methyl thiobenzoic acid protection against cisplatin ototoxicity: correlation of auditory brainstem responses and the antioxidant system [Abstr. 361.16]. Abstr Soc Neurosci 1995;21:910.